'This'll double the size of our company': Saratoga marketing firm scores big client

The latest deal for pharma marketing firm Peregrine Market Access will double the size of the company.  Peregrine has signed a three-year, “multimillion-dollar” agreement to lead the launch of a breakthrough bladder cancer diagnostic test called Oncuria developed by Los Angeles-based biotech startup Nonagen Bioscience. "It's a giant dollar amount. It is a significant win,” said John Guarino, Peregrine founder and president. “This'll double the size of our company with regards to people,…